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Centrally	located	renal	tumor	poses	a	diagnostic	challenge	to	differentiate	between	renal	cell	carcinoma	and	transi-
tional	cell	carcinoma.	Imaging	alone	is	not	sufficient	to	make	the	diagnosis,	some	invasive	diagnostic	investigations	






















































Renal cell carcinoma is a rare carcinoma accounting 
for 1.3 incidences per 100,000 Malaysian population [1]. Con-
trast-enhanced CT kidney and magnetic resonance imaging are 
the best imaging modalities to diagnose renal cell carcinoma, 
limiting invasive renal biopsies for only perceived metastatic 
disease [2]. However, distinguishing centrally renal cell carci-
noma from upper tract urothelial carcinoma on contrasted CT 
is challenging. Here, we would like to present one such case 
at our center and how we tackled this diagnostic dilemma.
Case presentation
60 years old, the gentleman presented to a private medical 
center with severe dyspepsia leading to detection of right renal pelvic 
mass on USG abdomen. Later, he was referred to us for further 
management.
History. The patient’s primary complaint was burning epigastric 
dyspepsia, which occurred suddenly in onset. He denies hematuria, 
flank pain or abdominal pain, or swellings. He does not have any 
family members with a history of malignancy. He is a known smoker 
and a retired army veteran. The patient has an underlying history 
of coronary artery bypass grafting done in 2002 for coronary artery 
disease. He too has hypertension and types 2 diabetes mellitus. 
Despite, lack of response initial treatment for his dyspepsia, lead 
physicians to order USG abdomen to rule out another differential 
diagnosis. This lead to incidental finding of right solid renal pelvis 
tumor and was referred to us.
Examination. Generally, the patient is a fit man who 
is ambulatory. Abdominal examinations were unremarkable, 
there were no palpable abdominal masses and kidneys were 
not ballotable.
Investigations. A contrasted CT kidney was ordered which 
showed a filling defect involving a right renal pelvis mass 
measuring 3.0 × 4.2 × 4.3 cm with no features of local invasion 
or lymphadenopathy (Fig. 1, 2). A right ureteroscopy was 
performed and no significant abnormality was detected at the 
right ureter. Right ureteric barbotage and cytology revealed 
mild atypia for the renal pelvis.
Diagnostic dilemma of renal cell carcinoma versus upper 
tract urothelial carcinoma encountered. To ascertain a diagnosis, 
a renal percutaneous biopsy was performed and a histopathology 
report revealed clear cell type, renal cell carcinoma WHO / ISUP 
Grade 2.
Management. Based on options of treatments given to pa-
tients. He opted and underwent robotic-assisted laparoscopic 
right radical nephrectomy. The patient recovered and was dis-
charged home after 5 days of stay inward.
Histopathology of the right kidney was reported as papillary 
renal cell carcinoma, type II, invading the renal sinus fat 
and renal capsule, stage T3aN0Mx by TNM AJCC 8th edition.
Discussion
Since the development of contrasted CT renal in the 
early 1990s, it had been routinely used to assess solid renal 
tumors. In most instances, radiologists can confidently 
diagnose a renal cell carcinoma based on CT and histopa-
thology reports will correlate [3]. However, in certain cir-
cumstances like a centrally located renal tumor, it may 
be challenging for the radiologist to distinguish between 
centrally located renal cell carcinoma, intrarenal transitional 
cell carcinoma (TCC), lymphoma, and metastasis to the kid-
ney [4]. Differentiating this centrally located renal cell car-
cinoma and intrarenal TCC are extremely important from 
a management point of view and also a follow-up of the patient 
after the intervention.
For localized renal cell carcinoma, the patient will be coun-
selled for radical nephrectomy and will have half-yearly follow 
up with CT scan, however, a case of upper tract urothelial 
carcinoma will need to undergo radical nephroureterectomy 
with retroperitoneal lymph node dissection and more in-
tense follow up with flexible cystoscopy and CT scan every 
quarter yearly [5, 6].
Enhancement of solid renal tumor and characteristic 
of the tumor had been used to define renal cell carcinoma 
based on CT images. Clear cell renal cell carcinomas 
Fig. 1. A coronal view CT image of the right renal tumour (left image). Right kid-
ney specimen, split-half, arrows pointing at right renal tumour (right image)
Fig. 2. Shows cut section of right kidney specimen, split into half. Right renal 












































enhance to a greater extent and has a heterogeneous ap-
pearance in comparison to non-clear cell renal cell carci-
nomas which are homogenous and have lesser parenchyma 
to tumor enhancement ratio [7]. On multidetector CT, 
pelvicalyceal TCC appears as single or multiple sessile fil ling 
defects which compresses on renal sinus fat with pelvicaly-
ceal irregularities like focal or diffuse mural thickening. 
Infiltrative pelvicalyceal TCCs usually present at more cen-
tral location, however rarely TCCs can present more eccentric 
or peripheral location. If eccentric infiltrative TCCs distorts 
normal reniform shape of kidney, it may mimic renal cell 
carcinoma [8].
Based on a study, S. A. Raza et al. had suggested looking 
for other signs such as a filling defect in the renal pelvis, 
tumor center within the renal pelvis, preservation of renal 
shape, absence of cystic / necrotic changes, tumor extending 
into the pelvic ureteric junction, and homogeneity of tumor 
which suggest intrarenal TCC. Yet, these signs have a speci-
ficity of 79–89 % and sensitivity of 68–82 % [4].
By going through previous reported cases and literature, 
we decided that CT alone may not suffice to provide a di-
agnosis in our case, which leads us to perform ureteroscopy 
and barbotage to obtain the right renal pelvis cytology which 
showed mild atypical cell. Ureteral barbotage cytology has 
a sensitivity of 77 % and specificity of 31 % [9].
Based on radiological, clinical, and biochemical findings 
was leading towards intrarenal TCC. A decision was made 
to ascertain diagnosis by invasive diagnostic technique to guide 
us to counsel patients on definitive surgical intervention. 
A percutaneous renal tumor biopsy revealed the diagnosis 
of renal cell carcinoma, much to the surprise of the attending 
urologist. Although, the majority of renal tumors can be di-
agnosed based on multiphasic CT renal alone. Certain tum-
ors such as a centrally located renal tumor in our case need 
further evaluation even if it involves an invasive diagnostic 
method. A diagnosis of malignancy is devastating news 
for the patient and the attending physician’s role is vital 
for proper management and outcome. Accurate diagnosis 
of the tumor prevents unnecessary intervention that can 
increase morbidity and even mortality.
Conclusion
Managing this individual case, thought us that a cen-
trally located renal tumor requires more than just multipha-
sic CT renal alone to conclude on the potential diagnosis 
of renal cell carcinoma.
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